treatment of Lennox-Gastaut syndrome (LGS)
All entries for: Bright Minds Biosciences, Inc.
July 26, 2026
Bright Minds Biosciences, Inc.
Orphan Drug Designation
New York
1-50 employees
Disease Area: Rare Diseases
treatment of Lennox-Gastaut syndrome (LGS)